Home » Topics » BioWorld Science

BioWorld Science
RSS

IRF3 orchestrates obesity-induced inflammation and dysglycemia

April 5, 2022

HCAR2 targeting modulates the progression of AD in mice

April 5, 2022

Molecular chaperone maintains proteostasis by clearing protein aggregates in cell

April 4, 2022

Blockade of PTGDR protects mice from severe SARS-CoV-2 infection

April 4, 2022

JS-009 cleared to advance into clinic in U.S. for advanced solid tumors

April 4, 2022

Researchers present [11C]JMJ-81 as a new PET tracer for brain PDE4D quantification

April 4, 2022

Discovery of alpha-syn aggregation inhibitors for the treatment of PD

April 4, 2022

LY-3372689, a novel OGA enzyme inhibitor for the treatment of Alzheimer's disease

April 4, 2022

Shanghai Litedd presents new RET inhibitors

April 4, 2022

Merck & Co. presents new KLKB1 inhibitors

April 4, 2022

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 31, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 31, 2025.
Researchers discover how glioblastoma tumors dodge chemotherapy
BioWorld MedTech
Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...
Shionogi nabs revenue-generating ALS drugs with $2.5B Tanabe pact
BioWorld
Shionogi & Co. Ltd. will acquire global rights to U.S. FDA approved amyotrophic lateral sclerosis therapy edaravone through a $2.5 billion acquisition deal with...
Big pharma taps fast Asia innovation in search of next Keytruda
BioWorld
Speed and innovation from Asia Pacific’s (APAC) biotechnology sector had big pharma scouring the region for the next oncology heir to Keytruda (pembrolizumab),...